Microbot Medical Inc. Common Stock (MBOT)
Stock · NASDAQ · Health Care
$0.95as of 10/16/2026
Price chart
MBOT Signal Track Record
How signals performed across all stocks →What MBOT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | -6.0% | 26% | October 5, 2026 |
| Bollinger Band Breakdown | 23 | -5.1% | 35% | October 5, 2026 |
| Bollinger Band Breakout | 19 | -5.0% | 26% | August 10, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -15.3% | 29% | April 10, 2026 |
| Any 20-session window (baseline) | -3.9% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MBOT
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, a…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 43
- Website
- www.microbotmedical.com/
Fundamentals
- 1-day range
- $0.93$0.99
- Market cap
- $120.90M
- P/E (trailing)
- —
- P/E (forward)
- -3.13
- EPS (trailing)
- $-0.26
- Dividend yield
- —
- Beta
- 1.01
- Avg. volume
- 653.6K
- Dividend pay date
- September 5, 2018
How Microbot Medical Inc. Common Stock Makes Money
Where the revenue actually goes — FY2015 annual results
Source: 10-K filed Mar 15, 2016 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Microbot Medical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MBOTMicrobot Medical Inc. Common Stock$0.95▲ 0.00%Market cap $120.90MP/E —$0.99$3.04
- GUTSFractyl Health Inc. Common Stock$1.55▼ 62.74%Market cap $108.99MP/E —$3.78$29.34
- SKINSkinHealth Systems Inc. Class A Common Stock$10.56▼ 16.19%Market cap $99.91MP/E —$10.01$34.8
- RCELAvita Medical Inc. Common Stock$13.04▼ 2.76%Market cap $146.19MP/E —$3.22$13.73
- PYPDPolyPid Ltd. Ordinary Shares$4.72▼ 3.67%Market cap $91.79MP/E —$3.1$5.73
- LUNGPulmonx Corporation Common Stock$1.78▼ 3.78%Market cap $88.04MP/E —$1.13$2.89
- STIMNeuronetics Inc. Common Stock$1.88▼ 3.33%Market cap $156.57MP/E —$0.8$3.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MBOT Microbot Medical Inc. Common Stock | $120.90M | — | $0.95 | ▲ 0.00% | $0.99$3.04 |
| GUTS Fractyl Health Inc. Common Stock | $108.99M | — | $1.55 | ▼ 62.74% | $3.78$29.34 |
| SKIN SkinHealth Systems Inc. Class A Common Stock | $99.91M | — | $10.56 | ▼ 16.19% | $10.01$34.8 |
| RCEL Avita Medical Inc. Common Stock | $146.19M | — | $13.04 | ▼ 2.76% | $3.22$13.73 |
| PYPD PolyPid Ltd. Ordinary Shares | $91.79M | — | $4.72 | ▼ 3.67% | $3.1$5.73 |
| LUNG Pulmonx Corporation Common Stock | $88.04M | — | $1.78 | ▼ 3.78% | $1.13$2.89 |
| STIM Neuronetics Inc. Common Stock | $156.57M | — | $1.88 | ▼ 3.33% | $0.8$3.44 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Microbot Medical® Highlights Growth StrategyYahoo · 9/25/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 13.76M
- Total value held
- $33.07M
- Institutional holders
- 78
- Unknown2.91M
- Unknown1.87M
- Unknown1.14M
- Unknown857.4K
- Unknown816.9K
- Unknown760.8K
- Unknown677.5K
- Unknown573.1K
- Unknown481.0K
- Unknown454.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Microbot Medical Outlines Growth Strategy
Microbot Medical highlighted its growth strategy in a recent update. The company shares are currently trading near their 52-week low, with technical indicators showing recent weakness. This news provides context for the stock's current position relative to analyst price targets.
Microbot Medical Outlines Growth Strategy. Microbot Medical highlighted its growth strategy in a recent update. The company shares are currently trading near their 52-week low, with technical indicators showing recent weakness. This news provides context for the stock's current position relative to analyst price targets.